CD8A and neoplasm: The tumor modulating effect of SEA-TGT was examined in another syngeneic model, MC38, and here a more prominent, significant decrease of Tregs was observed (Supplemental Figure 2E), though no changes in CD4 or CD8 were seen in this model.